Caris Aug 12, 2022 In Brief This Week: AstraZeneca, Merck, Stemline Therapeutics, Caris Life Sciences, Artios Pharma Jul 22, 2022 In Brief This Week: Oryzon Genomics, Byondis, Caris Life Sciences, Natera Jul 14, 2022 Synthetic Control Arms Finding Stronger Footing in Precision Oncology Trials, Regulatory Submissions Premium Jul 7, 2022 Caris Life Sciences Expands Partnership With Epic to Improve Molecular Testing Access Jul 1, 2022 In Brief This Week: Lungevity, Grail, Mainz Biomed, Bayer, Scorpion, Caris Life Sciences Jun 2, 2022 Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership May 6, 2022 In Brief This Week: OncoHost, Matica Biotechnology, Xilis, Aptose Biosciences, Cigna Apr 14, 2022 In Brief This Week: Artemis DNA, ITM Isotope Technologies, BriaCell, Caris Life Sciences Mar 29, 2022 Zentalis Pharmaceuticals, Caris Life Sciences Ink Precision Oncology Partnership Mar 10, 2022 Caris Life Sciences to Help ID Patients for Pyramid Biosciences' Cancer Drug Study Mar 4, 2022 In Brief This Week: JW Therapeutics, Caris Life Sciences, AnHeart Therapeutics, Innovent Biologics Feb 11, 2022 In Brief This Week: Caris Life Sciences, OSUCC, National Cancer Center Japan, Phoenix Molecular Designs Dec 6, 2021 Redx Pharma, Caris Life Sciences Partner for Colorectal Cancer Phase II Drug Study Recruitment Nov 12, 2021 In Brief This Week: AstraZeneca, CytoDyn, BerGenBio, Bayer, Dana-Farber Cancer Institute, Kronos Bio Oct 29, 2021 In Brief This Week: LUNGevity Foundation, Caris Life Sciences, Deep Lens, Genetic Technologies Oct 14, 2021 Caris Life Sciences, Ono Pharmaceutical Ink Cancer Drug Development Collaboration Oct 7, 2021 Caris Life Sciences, Essa Pharma Ink Liquid Biopsy Partnership for Prostate Cancer Trial Aug 27, 2021 In Brief This Week: Roche, Immunocore, OrigiMed, Mount Sinai, Caris Life Sciences, CellMax Life Jun 15, 2021 Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development Jun 2, 2021 Rain Therapeutics Partners With Caris to Enroll Patients for MDM2 Inhibitor Basket Trial Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week: Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
